NO970437D0 - (-) - (3R) -3-methyl-4- {4- [4- (4-pyridyl) piperazin-1-yl] phenoxy} butyric acid as cellular adhesion inhibitor - Google Patents

(-) - (3R) -3-methyl-4- {4- [4- (4-pyridyl) piperazin-1-yl] phenoxy} butyric acid as cellular adhesion inhibitor

Info

Publication number
NO970437D0
NO970437D0 NO970437A NO970437A NO970437D0 NO 970437 D0 NO970437 D0 NO 970437D0 NO 970437 A NO970437 A NO 970437A NO 970437 A NO970437 A NO 970437A NO 970437 D0 NO970437 D0 NO 970437D0
Authority
NO
Norway
Prior art keywords
piperazin
phenoxy
pyridyl
methyl
butyric acid
Prior art date
Application number
NO970437A
Other languages
Norwegian (no)
Other versions
NO307460B1 (en
NO970437L (en
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO970437D0 publication Critical patent/NO970437D0/en
Publication of NO970437L publication Critical patent/NO970437L/en
Publication of NO307460B1 publication Critical patent/NO307460B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO970437A 1995-06-01 1997-01-31 Optically Active Compounds, Methods of Preparation thereof, Pharmaceutical Mixture and Use thereof NO307460B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative
PCT/GB1996/001260 WO1996038416A1 (en) 1995-06-01 1996-05-28 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor

Publications (3)

Publication Number Publication Date
NO970437D0 true NO970437D0 (en) 1997-01-31
NO970437L NO970437L (en) 1997-02-20
NO307460B1 NO307460B1 (en) 2000-04-10

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970437A NO307460B1 (en) 1995-06-01 1997-01-31 Optically Active Compounds, Methods of Preparation thereof, Pharmaceutical Mixture and Use thereof

Country Status (31)

Country Link
EP (1) EP0796247A1 (en)
JP (1) JP2885941B2 (en)
KR (1) KR100245957B1 (en)
AT (1) AT406675B (en)
AU (1) AU710105B2 (en)
BE (1) BE1009520A5 (en)
BR (1) BR9606409A (en)
CA (1) CA2194397A1 (en)
CH (1) CH691808A5 (en)
CZ (1) CZ26997A3 (en)
DE (1) DE19680509T1 (en)
DK (1) DK10697A (en)
ES (1) ES2137886B1 (en)
FI (1) FI970393A (en)
GB (1) GB2304340B (en)
GR (1) GR1002702B (en)
HU (1) HUP9700274A3 (en)
IE (1) IE960405A1 (en)
IL (1) IL118477A0 (en)
IT (1) IT1290839B1 (en)
LU (1) LU90008B1 (en)
MC (1) MC2418A1 (en)
MX (1) MX9700379A (en)
NL (1) NL1003243C2 (en)
NO (1) NO307460B1 (en)
NZ (1) NZ308597A (en)
PL (1) PL318440A1 (en)
SE (1) SE510812C2 (en)
SK (1) SK13097A3 (en)
TR (1) TR199700020T1 (en)
WO (1) WO1996038416A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
SK120895A3 (en) * 1993-03-29 1996-06-05 Zeneca Ltd Pyridine derivatives, process for preparing the same and intermediate products in this process and pharmaceutical compositions containing them
NZ262942A (en) * 1993-03-29 1997-07-27 Zeneca Ltd Pyridyl substituted piperazine and various other derivatives of azaheteroaryl substituted piperazines; pharmaceutical compositions

Also Published As

Publication number Publication date
FI970393A0 (en) 1997-01-30
MX9700379A (en) 1997-04-30
LU90008B1 (en) 1997-04-16
KR100245957B1 (en) 2000-04-01
HUP9700274A2 (en) 1999-06-28
CH691808A5 (en) 2001-10-31
WO1996038416A1 (en) 1996-12-05
SE510812C2 (en) 1999-06-28
ATA900596A (en) 1999-12-15
AU710105B2 (en) 1999-09-16
MC2418A1 (en) 1997-05-23
SE9700203D0 (en) 1997-01-24
FI970393A (en) 1997-01-30
NO307460B1 (en) 2000-04-10
CA2194397A1 (en) 1996-12-05
AT406675B (en) 2000-07-25
EP0796247A1 (en) 1997-09-24
GB9627127D0 (en) 1997-02-19
SK13097A3 (en) 1997-08-06
NO970437L (en) 1997-02-20
ES2137886B1 (en) 2000-08-16
DE19680509T1 (en) 1997-12-04
HUP9700274A3 (en) 2000-02-28
CZ26997A3 (en) 1997-08-13
TR199700020T1 (en) 1997-04-22
SE9700203L (en) 1997-01-24
GB2304340B (en) 1998-07-29
JPH09512836A (en) 1997-12-22
ES2137886A1 (en) 1999-12-16
BE1009520A5 (en) 1997-04-01
IL118477A0 (en) 1996-09-12
IT1290839B1 (en) 1998-12-14
JP2885941B2 (en) 1999-04-26
AU5827296A (en) 1996-12-18
DK10697A (en) 1997-04-01
ITMI961113A1 (en) 1997-12-01
GB2304340A (en) 1997-03-19
PL318440A1 (en) 1997-06-09
HU9700274D0 (en) 1997-04-28
GR1002702B (en) 1997-05-22
KR970704689A (en) 1997-09-06
BR9606409A (en) 1997-09-30
NL1003243C2 (en) 1996-12-04
NZ308597A (en) 1998-11-25
IE960405A1 (en) 1996-12-11
ITMI961113A0 (en) 1996-05-31

Similar Documents

Publication Publication Date Title
DK1036062T3 (en) Hydroxamic acid derivatives such as matrix metalloprotease (MMP) inhibitors
FI973360A (en) Novel dipeptidic amidines as thrombin inhibitors
DK0925303T3 (en) Phosphinic acid amides as matrix metalloprotease inhibitors
DK0821671T3 (en) Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors
NO993587L (en) Sulfonamide metalloprotease inhibitors
DK0934259T3 (en) Beta-sulfonamidohydroxamic acids as matrix metalloproteinase and TACE inhibitors
NO991994D0 (en) Substituted 4-biphenyl-4-hydroxy acid derivatives as matrix metalloprotease inhibitors
NO991316L (en) 3-Mercaptoacetylamino-1,5-substituted-2-oxo-azepane derivatives useful as inhibitors of matrix metalloproteinase
NO911459D0 (en) USE OF METALLION COMPLEXS AS INVESTMENT INHIBITORS.
NO970437D0 (en) (-) - (3R) -3-methyl-4- {4- [4- (4-pyridyl) piperazin-1-yl] phenoxy} butyric acid as cellular adhesion inhibitor
GB9610093D0 (en) (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid
ZA964509B (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyric acid
NO965353D0 (en) 3-Amino-2-oxo-1-piperidinedacetic acid derivatives as enzyme inhibitors
KR970000223A (en) Cholesterol biosynthesis inhibitors
NO950212L (en) Indolinyl-N-hydroxyurea and -N-hydroxamic acid derivatives as lipoxygenase inhibitors
NO986204L (en) 4- (4-oxocyclohexyl) benzamides as intermediates for drugs
ID18481A (en) 2- (3,5-DIFLUOROFENIL) -3- (4-METYLSULFONIL) FENIL) -2-CYCLOPENTEN-1-ON USING AS COX-2 INHIBITORS

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2002